These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15119371)

  • 1. Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy.
    Berry A; Abraham B; Dereure J; Pinzani V; Bastien P; Reynes J
    Scand J Infect Dis; 2004; 36(3):225-7. PubMed ID: 15119371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated visceral leishmaniasis.
    Pintado V; López-Vélez R
    Clin Microbiol Infect; 2001 Jun; 7(6):291-300. PubMed ID: 11442562
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-kala-azar dermal Leishmaniasis in two different clinical contexts.
    Barroso DH; Silva CE; Perdigao e Vasconcelos AC; Cavalcanti SM; Brito ME; Medeiros AC
    An Bras Dermatol; 2015; 90(3 Suppl 1):108-10. PubMed ID: 26312689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)].
    Berenguer J; Cosín J; Miralles P; López JC; Padilla B
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):133. PubMed ID: 11904089
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis presenting as subcutaneous nodules in a HIV-positive patient.
    Göbels K; Feldt T; Oette M; Richter J; Harms G; Grobusch MP; Sarbia M; Häussinger D
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):329-31. PubMed ID: 12736797
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment: immune reconstitution syndrome--the double-edged sword of early immune recovery.
    Carey J
    AIDS Read; 2005 Feb; 15(2):74-5. PubMed ID: 15712397
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.
    Mastroianni A
    Infez Med; 2004 Sep; 12(3):197-204. PubMed ID: 15711134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of visceral leishmaniasis in HIV infection.
    Jarvis JN; Lockwood DN
    Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
    Patel TA; Lockwood DN
    Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visceral leishmaniasis and HIV infection in the HAART era].
    Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
    Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of highly active antiretroviral therapy on the clinical onset of AIDS defined by clinical episodes].
    Fernández-Rivera J; Macías J; García-García JA; Ramos AJ; Leal M; Pineda JA
    Med Clin (Barc); 2002 May; 118(18):686-8. PubMed ID: 12042131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HIV-positive man with tattoo induration.
    López-Medrano F; Costa JR; Rodriguez-Peralto JL; Aguado JM
    Clin Infect Dis; 2007 Jul; 45(2):220-1, 267-8. PubMed ID: 17578782
    [No Abstract]   [Full Text] [Related]  

  • 14. Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals.
    Tumbarello M; Tacconelli E; Bertagnolio S; Cauda R
    AIDS; 2000 Dec; 14(18):2948-9. PubMed ID: 11153680
    [No Abstract]   [Full Text] [Related]  

  • 15. Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy.
    Rosenthal E; Tempesta S; Del Giudice P; Marty P; Desjeux P; Pradier C; Le Fichoux Y; Cassuto JP
    AIDS; 2001 Jun; 15(9):1184-5. PubMed ID: 11416724
    [No Abstract]   [Full Text] [Related]  

  • 16. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.
    Davidson RN; Di Martino L; Gradoni L; Giacchino R; Russo R; Gaeta GB; Pempinello R; Scott S; Raimondi F; Cascio A
    Q J Med; 1994 Feb; 87(2):75-81. PubMed ID: 8153291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment.
    Saikia L; Nath R; Biswanath P; Hazarika D; Mahanta J
    Indian J Med Res; 2009 Mar; 129(3):333-4. PubMed ID: 19491430
    [No Abstract]   [Full Text] [Related]  

  • 18. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptosporidiosis presenting as acute appendicitis: a case report.
    Buch K; Nguyen S; Divino CM; Weber K; Morotti RA
    Am Surg; 2005 Jun; 71(6):537-8. PubMed ID: 16044940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.